Back to announcement
20231031_INAF_Laporan Informasi dan Fakta Material_31483817_lamp1.pdf
Financial statement Text extracted INAFSource file signed link, expires in 15 minutes
Extracted text 1
Page 1 OCR 0.903
indofarma Jakarta, 21 November 2022 Nomor 1883/DIR/XI/2022 Lampiran Ada Perihal Penyampaian Laporan Keuangan Interim Konsolidasian PT Indofarma Tbk dan Entitas Anak Per 30 September 2022 (Unaudited) dan 30 September 2021 (Unaudited) serta periode yang berakhir 30 September 2022 dan 30 September 2022. Kepada Yth. Kepala Eksekutif Pengawas Pasar Modal Otoritas Jasa Keuangan Gedung Sumitro Djojohadikusumo Kementerian Keuangan RI Jl. Lapangan Banteng Timur No. 2-4 Jakarta Pusat Dengan hormat, Bersama ini kami sampaikan Laporan Keuangan Interim Konsolidasian PT Indofarma Tbk dan Entitas Anak Per 30 September 2022 (Unaudited) dan 30 September 2021 (Unaudited) serta periode yang berakhir 30 September 2022 (Unaudited) dan 30 September 2021 (Unaudited). Demikian kami sampaikan. Atas perhatiannya kami ucapkan terima kasih. Hormat kami, PT Indofarma Tbk Arfan Jyariet Pramuhani Direktur Utama Tembusan: - Direktur Penilaian Perusahaan PT Bursa Efek Indonesia PT Indofarma Tok Ph, 62-21 Jl. Indofarma No.1, Cikarang Barat Fx. 62-21 Bokasi 17530 - Indonesia 1323971/75 Emall: hendotficeindot: www Indofarma.id
Names mentioned 0 people and organisations named in the text · linked when the evidence is strong
The name pass has not read this document yet.
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.